176 related articles for article (PubMed ID: 17617542)
1. Field evaluation of an oral attenuated Lawsonia intracellularis vaccine for porcine proliferative enteropathy (ileitis).
McOrist S; Smits RJ
Vet Rec; 2007 Jul; 161(1):26-8. PubMed ID: 17617542
[No Abstract] [Full Text] [Related]
2. Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions.
Jacobs AAC; Harks F; Hazenberg L; Hoeijmakers MJH; Nell T; Pel S; Segers RPAM
Vaccine; 2019 Apr; 37(15):2149-2157. PubMed ID: 30867100
[TBL] [Abstract][Full Text] [Related]
3. [Field study about the use of Enterisol Ileitis in a swine herd in Switzerland].
Caspari K; Kümmerlen D; Voets H; Eichin E; Zeeh H; Zimmermann W
Schweiz Arch Tierheilkd; 2009 Jan; 151(1):31-2. PubMed ID: 19160169
[No Abstract] [Full Text] [Related]
4. Proliferative enteropathy: a global enteric disease of pigs caused by Lawsonia intracellularis.
Kroll JJ; Roof MB; Hoffman LJ; Dickson JS; Harris DL
Anim Health Res Rev; 2005 Dec; 6(2):173-97. PubMed ID: 16583781
[TBL] [Abstract][Full Text] [Related]
5. Effect of a live attenuated vaccine against Lawsonia intracellularis in weaned and finishing pig settings in Finland.
Peiponen KS; Tirkkonen BT; Junnila JJT; Heinonen ML
Acta Vet Scand; 2018 Mar; 60(1):18. PubMed ID: 29566718
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral vaccination against Lawsonia intracellularis on growing-finishing pig's performance in a pig production unit with endemic porcine proliferative enteropathy (PPE).
Almond PK; Bilkei G
Dtsch Tierarztl Wochenschr; 2006 Jun; 113(6):232-5. PubMed ID: 16856610
[TBL] [Abstract][Full Text] [Related]
7. Effect of the route of administration on the mucosal and systemic immune responses to Lawsonia intracellularis vaccine in pigs.
Nogueira MG; Collins AM; Dunlop RH; Emery D
Aust Vet J; 2015 Apr; 93(4):124-6. PubMed ID: 25817978
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the humoral immune response and fecal shedding in weanling foals following oral and intra-rectal administration of an avirulent live vaccine of Lawsonia intracellularis.
Pusterla N; Hilton H; Wattanaphansak S; Collier JR; Mapes SM; Stenbom RM; Gebhart C
Vet J; 2009 Dec; 182(3):458-62. PubMed ID: 18835201
[TBL] [Abstract][Full Text] [Related]
9. Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy.
Montesino R; Gutiérrez N; Camacho F; Farnós O; Andrades S; González A; Acosta J; Cortez-San Martín M; Sánchez O; Ruiz A; Toledo JR
Vaccine; 2019 Feb; 37(10):1340-1349. PubMed ID: 30711318
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of pigs with attenuated Lawsonia intracellularis induced acute phase protein responses and primed cell-mediated immunity without reduction in bacterial shedding after challenge.
Riber U; Heegaard PM; Cordes H; Ståhl M; Jensen TK; Jungersen G
Vaccine; 2015 Jan; 33(1):156-62. PubMed ID: 25444804
[TBL] [Abstract][Full Text] [Related]
11. An attenuated
Park S; Won G; Lee JH
J Vet Sci; 2019 May; 20(3):e24. PubMed ID: 31161742
[TBL] [Abstract][Full Text] [Related]
12. Defining the full costs of endemic porcine proliferative enteropathy.
McOrist S
Vet J; 2005 Jul; 170(1):8-9. PubMed ID: 15993784
[No Abstract] [Full Text] [Related]
13. Relationship between the severity of porcine proliferative enteropathy and the infectious dose of Lawsonia intracellularis.
Guedes RM; Winkelman NL; Gebhart CJ
Vet Rec; 2003 Oct; 153(14):432-3. PubMed ID: 14582733
[No Abstract] [Full Text] [Related]
14. A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function.
Roerink F; Morgan CL; Knetter SM; Passat MH; Archibald AL; Ait-Ali T; Strait EL
Vaccine; 2018 Mar; 36(11):1500-1508. PubMed ID: 29336925
[TBL] [Abstract][Full Text] [Related]
15. Porcine proliferative enteropathy: an important disease with questions remaining to be solved.
Jacobson M; Fellström C; Jensen-Waern M
Vet J; 2010 Jun; 184(3):264-8. PubMed ID: 19487140
[TBL] [Abstract][Full Text] [Related]
16. Distinction between porcine circovirus type 2 enteritis and porcine proliferative enteropathy caused by Lawsonia intracellularis.
Jensen TK; Vigre H; Svensmark B; Bille-Hansen V
J Comp Pathol; 2006 Nov; 135(4):176-82. PubMed ID: 17070535
[TBL] [Abstract][Full Text] [Related]
17. Immunological responses to vaccination following experimental Lawsonia intracellularis virulent challenge in pigs.
Nogueira MG; Collins AM; Donahoo M; Emery D
Vet Microbiol; 2013 May; 164(1-2):131-8. PubMed ID: 23478250
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the field efficacy of an avirulent live Lawsonia intracellularis vaccine in foals.
Nogradi N; Slovis NM; Gebhart CJ; Wolfsdorf KE; McCracken JL; Scoggin CF; Kass PH; Mapes SM; Toth B; Lundquist ML; Pusterla N
Vet J; 2012 Jun; 192(3):511-3. PubMed ID: 21741284
[TBL] [Abstract][Full Text] [Related]
19. Immunoproteomic analysis of Lawsonia intracellularis identifies candidate neutralizing antibody targets for use in subunit vaccine development.
Obradovic M; Pasternak JA; Hon Ng S; Allan B; Brownlie R; Wilson HL
Vet Microbiol; 2019 Aug; 235():270-279. PubMed ID: 31383312
[TBL] [Abstract][Full Text] [Related]
20. Current infection patterns of porcine proliferative enteropathy in Great Britain and the Republic of Ireland.
Hands I; McOrist S; Blunt R; Lawrence K
Vet Rec; 2010 Aug; 167(9):343-4. PubMed ID: 20802189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
